Comparison of raloxifene effect on the growth and angiogenesis of human endometrium of healthy and endometriosis subjects: An in vitro three-dimensional tissue culture model
article
OA: closed
CC0
⤵ 1 in-corpus citation
Abstract
Introduction: Raloxifene (Ral) is the oldest SERM (selective oestrogen receptor modulators) for treatment of breast cancer and osteoporosis. Its oestrogen-modulating effects have been shown in breast and uterus. Since there is little available data on direct Ral effect on the human endometrium, the aim of present study was to investigate the Ral effect on the growth and angiogenesis of the human endometrium of healthy and endometriosis subjects in an in vitro three-dimensional (3D) tissue culture model. Material and methods: Endometrial biopsies from healthy ( n = 9) and endometriosis ( n = 7) patients (endometriotic) were taken and were cut into 1 × 1 mm fragments and implanted between two layers of fibrin jell made by fibrinogen solution (3 mg/ml in medium 199+thrombin). Tissue cultures were performed in 24-wel culture plates. Each biopsy was divided into control wells which received M199 supplemented with FBS (5%) and experimental wells which received same media containing one of raloxifene doses (0.1, 1 and 10 μM). Endometrial tissues were photographed at the beginning and the end of the study period (21 days). Tissue growth and angiogenesis were determined by a scoring system. Results: In control (0), 0.1, 1 and 10 μM Ral, the growth score of normal human endometrial tissues were 1.99, 1.72, 1.53 and 1.12 ( p = 0.02) and angiogenesis percent were 29.6%, 31.28%, 33% and 11.5%. The Growth scores of the endometriotic endometrium were 1.92, 1.82, 1.92 and 1.1 ( p = 0.008) and angiogenesis percent were 36.6%, 16.6%, 44% and 12.5% respectively. Conclusion: Raloxifene showed a different dose dependent effect on endometrial and endometriotic tissue.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Validation of Rat Endometriosis Model by Using Raloxifene as a Positive Control for the Evaluation of Novel SERM Compounds 2005
- Three-dimensional in vitro culture of endometrial explants mimics the early stages of endometriosis 2003
- Letrozole stimulates the growth of human endometrial explants cultured in three-dimensional fibrin matrix 2008
- Noscapine Inhibiting the Growth and Angiogenesis of Human Eutopic Endometrium of Endometriosis Patients through Expression of Apoptotic Genes and Nitric Oxide Reduction in Three-Dimensional Culture Model. 2019
Cited by (1)
References (24)
- Letrozole stimulates the growth of human endometrial explants cultured in three-dimensional fibrin matrix via openalex
- Noscapine Inhibiting the Growth and Angiogenesis of Human Eutopic Endometrium of Endometriosis Patients through Expression of Apoptotic Genes and Nitric Oxide Reduction in Three-Dimensional Culture Model. via openalex
- Three-dimensional in vitro culture of endometrial explants mimics the early stages of endometriosis via openalex
- Validation of Rat Endometriosis Model by Using Raloxifene as a Positive Control for the Evaluation of Novel SERM Compounds via openalex
- W2025227029 via openalex
- W2027775543 via openalex
- W2039889539 via openalex
- W2051676088 via openalex
- W2061948111 via openalex
- W2065022554 via openalex
- W2068225885 via openalex
- W2072183288 via openalex
- W2113907939 via openalex
- W2126824378 via openalex
- W2139093121 via openalex
- W2163201771 via openalex
- W2163248521 via openalex
- W2330966147 via openalex
- W3016339115 via openalex
- W1563890385 via openalex
- W4255273931 via openalex
- W1971909806 via openalex
- W1973649821 via openalex
- W1997883187 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-05T02:00:03.366016+00:00
License: CC0
· commercial use OK